Medicare Lab Test Coverage: When Blood Work Costs Nothing and When It Doesn't

17 min read

For a covered clinical lab test under Original Medicare, you usually pay nothing. No Part B deductible, no 20% coinsurance, and no charge for the blood draw itself. That's the rule in CMS's own claims manual, and Medicare.gov puts it plainly: "You usually pay nothing."

The catch is the word "covered." The test has to be ordered by the doctor treating you, it has to be medically necessary for a diagnosis on the order, and it can't run past a frequency limit Medicare has set. Miss one of those and the lab can bill you its own price, provided it warned you in writing first. When a "lab" bill does show up, check three places first: a test Medicare treats as too frequent or not necessary, a charge that isn't actually a clinical lab test (pathology, imaging), or a hospital outpatient visit where the lab work was folded into a bigger bill.

Your share, covered lab testNothingNo deductible, no coinsurance
National lab coverage rules23Negotiated NCDs for common tests
Part B lab spending, 2024$8.4BUp 5% from 2023
Lab tests paid by Part B, 2024380M16 per enrollee, OIG average

Source: Medicare.gov, Diagnostic laboratory tests; CMS Claims Processing Manual ch. 16, secs. 30.2 and 120.2; HHS OIG data snapshot OEI-09-25-00330.

The rule: why you usually pay nothing

Part B covers diagnostic laboratory tests when your health care provider orders them and they're medically necessary. Medicare.gov describes them as tests that "help your doctor or other health care provider diagnose or rule out a suspected illness or condition," including certain blood tests, urinalysis and certain tests on tissue specimens.

The cost-sharing rule lives in section 30.2 of the Medicare Claims Processing Manual, chapter 16. Neither the annual deductible nor the 20% coinsurance applies to clinical lab tests done by a physician, laboratory or other entity paid on an assigned basis, to specimen collection fees, or to a lab's travel allowance for collecting a specimen. So the needle stick at the draw station is covered the same way as the test.

That means the Part B deductible, $283 in 2026 per the CMS 2026 fact sheet, doesn't come into play for a covered clinical lab test. CMS hadn't announced the 2027 deductible as of November 16, 2026; it usually publishes the new Part B figures in the fall. Whatever the 2027 number turns out to be, it won't change the no-cost rule for covered lab tests.

Two conditions sit underneath all of this:

  • A treating practitioner orders it. Under 42 CFR 410.32(a), diagnostic lab tests must be ordered by the physician treating you for a specific problem who uses the results to manage it. Nurse practitioners and physician assistants working within their scope count too. A test nobody treating you ordered is "not reasonable and necessary" by regulation.
  • A diagnosis travels with the order. CMS requires a diagnosis on every lab claim, and the lab can't make one up. It has to come from the ordering practitioner (ch. 16, sec. 120.1). That diagnosis code is what Medicare's software checks against its coverage rules.

One more line from that section matters if you like to "get everything checked": tests done without signs, symptoms, complaints, or personal history of disease or injury aren't covered unless a law specifically covers them as screening. A test to rule something out because you have a symptom is diagnostic. No symptom and no screening benefit means Medicare won't pay.

What you pay depends on what and where

Some of what shows up on a bill as "lab work" isn't a clinical lab test at all, and the setting changes how it's paid.

Lab and test costs under Original Medicare Part B
SituationWhat you pay under Original Medicare
Covered clinical lab test at an independent lab or your doctor's officeNothing; deductible and coinsurance don't apply
Blood draw or other specimen collection feeNothing
Lab-only visit to a hospital outpatient lab (no other outpatient service that day)Nothing; paid on the lab fee schedule
Lab tests during a hospital outpatient visit with other servicesLab work is generally packaged into the hospital's payment for the visit; your cost sharing follows the other outpatient services
Clinical lab services at a Critical Access HospitalNo coinsurance, deductible or copayment
Lab work during a Part A inpatient stayIncluded in the Part A hospital payment
Pathologist's exam of a biopsy (surgical pathology)Paid as a physician service; Part B deductible and 20% coinsurance generally apply
X-ray, CT, MRI, EKG (diagnostic, but not lab tests)20% after the Part B deductible; plus a hospital copayment in an outpatient department
Test Medicare considers not medically necessary or too frequent, with a valid ABNThe lab's charge, which isn't limited to Medicare's rate
Over-the-counter home COVID-19 testNot covered by Part B since May 12, 2023

Source: CMS Claims Processing Manual ch. 16, secs. 30.2, 30.3, 60; ch. 12, sec. 60; ch. 30, sec. 50.9; Medicare.gov, Diagnostic non-laboratory tests; CMS, COVID-19 OTC tests.

The hospital row is the one that confuses people. Since January 1, 2014, hospitals paid under Medicare's outpatient system generally don't get separate payment for lab tests done alongside other outpatient care that day. The labs are bundled into the payment for the main service. You won't see a separate lab coinsurance, but you'll owe whatever cost sharing applies to the visit, the infusion or the procedure the labs were part of. If you only go to the hospital lab for a blood draw and nothing else, the test is paid on the lab fee schedule and you owe nothing (ch. 16, sec. 30.3).

Pathology is the other trap. When a doctor sends a biopsy out, a pathologist examines the tissue. CMS treats surgical pathology, "the gross and microscopic examination of organ tissue performed by a physician," as a physician service paid under the physician fee schedule (ch. 12, sec. 60), and codes on that schedule are generally subject to the deductible and 20% coinsurance. So a skin biopsy can produce a pathology bill even though your routine blood work never did.

Assignment matters for one narrow reason. The no-cost rule applies to lab tests paid on an assigned basis. Medicare.gov's PSA page shows how it plays out: if the doctor who orders a PSA doesn't accept assignment, you may owe an extra fee for the doctor's services, "but not for the test itself."

Screening lab tests and their limits

Screening tests are the exception to the "no symptoms, no coverage" rule. Medicare has specific screening benefits, set by law or by national coverage decisions, each with its own eligibility and frequency. Stay inside them and you pay nothing when the provider accepts assignment. Go outside them, such as a cholesterol screening three years after the last one, and the test isn't covered as a screening.

Medicare Part B screening lab tests: eligibility and frequency
Screening lab testWho qualifiesHow often
Cardiovascular screening blood tests (cholesterol, lipids, triglycerides)Anyone with Part BOnce every 5 years
Diabetes screening (fasting or non-fasting glucose, A1C)At risk, by Medicare's risk-factor listUp to 2 a year
Hepatitis B screeningHigh risk, or pregnant; must be orderedYearly if at continued high risk and unvaccinated
Hepatitis C screeningBorn 1945 to 1965, transfusion before 1992, or injection drug useOnce in a lifetime; yearly with continued high risk
HIV screeningAges 15 to 65, or outside that range at increased riskOnce a year; up to 3 times in a pregnancy
PSA blood testMen over 50Once every 12 months
Pap test (lab), with HPV test as part of itPart B covers Pap tests and pelvic exams; HPV test if 30 to 65 with no HPV symptomsOnce every 24 months in most cases; every 12 months if high risk or of child-bearing age with an abnormal Pap in the past 36 months; HPV once every 5 years
STI screening (chlamydia, gonorrhea, syphilis, hepatitis B)Pregnant or at increased risk; must be orderedOnce every 12 months
Fecal occult blood testAge 45 and older, with a referralOnce every 12 months
Multi-target stool DNA testAges 45 to 85, no symptoms, average riskEvery 3 years
Blood-based biomarker test for colorectal cancerAges 45 to 85, no symptoms, average riskEvery 3 years

Source: Medicare.gov coverage pages: cardiovascular, diabetes, hepatitis B, hepatitis C, HIV, prostate, cervical, STI, fecal occult blood, stool DNA, blood-based biomarker.

For diabetes screening, Medicare.gov lists the qualifying risk factors: high blood pressure, a history of abnormal cholesterol and triglyceride levels, obesity, or a history of high blood sugar. Two or more of these also qualify: being 65 or older, being overweight, a parent or sibling with diabetes, or a history of gestational diabetes or delivering a baby over 9 pounds. If you're 65 or older, one more factor from that second list qualifies you.

Here's the distinction that trips people up. If you already have high cholesterol and your doctor checks a lipid panel to see whether your medication is working, that isn't the five-year screening. It's a diagnostic test for a known condition, and it's covered under a different set of rules (next section). The same goes for an A1C if you already have diabetes. And if a stool test comes back positive, Medicare covers the follow-up colonoscopy as a screening test.

The screening blood tests often get ordered around your annual wellness visit. For the full list of covered screenings, shots and counseling, including the ones that aren't lab tests, see my post on Medicare preventive services.

Medical necessity and the 23 lab NCDs

For the lab tests ordered most often, Medicare doesn't leave "medically necessary" to each claims contractor's judgment. Under a negotiated rulemaking that the Balanced Budget Act of 1997 required, CMS wrote 23 national coverage determinations (NCDs) for clinical diagnostic lab services. They apply nationwide, to every lab, hospital and doctor's office billing Part B (ch. 16, sec. 120.2).

Each NCD sorts every diagnosis code into one of three lists: codes covered by Medicare, codes denied, and codes that don't support medical necessity. Software on the claims system checks each lab claim against those lists automatically. That's why the diagnosis your doctor writes on the order matters so much. The same test can be paid with one diagnosis code and denied with another.

Examples from Medicare's 23 lab NCDs (190.12 to 190.34)
NCDTestWhat the NCD's limits say
190.15Blood counts (CBC)Testing someone with no symptoms and no condition that could cause a blood abnormality is screening, and not covered
190.21Glycated hemoglobin (A1C)Not more often than every 3 months for controlled diabetes; more often needs documentation
190.22Thyroid testingUp to 2 times a year when stable; more if therapy changes or symptoms appear
190.23Lipid testingAnnual panel usually adequate for monitoring; a component up to 6 times in the first year of therapy; LDL or total cholesterol 3 times a year once goals are met
190.31Prostate specific antigen (diagnostic)With urinary symptoms, generally once a year unless your condition changes
190.34Fecal occult blood test (diagnostic)For people on NSAIDs with a history of GI bleeding and no other signs, generally no more than every 3 months

Source: CMS National Coverage Determinations Manual, ch. 1, part 3, secs. 190.12-190.34; Claims Processing Manual ch. 16, sec. 120.2.

The A1C rule shows how this works. NCD 190.21 says it's "not considered reasonable and necessary" to run an A1C more often than every 3 months on someone whose diabetes is controlled. If your diabetes is uncontrolled, more frequent testing can be covered, but the medical record has to back it up. If your doctor wants an A1C every 6 weeks, ask what's in the chart to justify it before you go to the lab.

Tests outside the 23 NCDs can have frequency limits set in local coverage determinations (LCDs) from your region's Medicare contractor (ch. 30, sec. 40.2).

The ABN: when a lab can bill you

Medicare's financial protection for you is the Advance Beneficiary Notice of Non-coverage, form CMS-R-131. If a lab or doctor expects Medicare to deny a test as not reasonable and necessary, it has to tell you in writing before the test, explain why, and let you decide. Independent labs use it, and when a doctor orders the test and a separate lab runs it, either one can hand you the notice (ch. 30, secs. 50 and 50.3).

Here's what the rules say about how that notice works:

  • It has to be specific. CMS doesn't accept "generic" or "blanket" notices that say Medicare might deny anything, and a notice you sign blank is invalid. The ABN must name the test and give a real reason to expect denial.
  • Frequency limits are the exception. When Medicare has a frequency limit, a lab can give the ABN routinely, as long as it states the limit as the reason. That's why you might be handed one at the draw station for a cholesterol screening or an A1C.
  • It can include a cost estimate. The instructions let a lab give one estimate for a group of tests (ABN form instructions).
  • If you sign and Medicare denies, you can owe the lab's usual fee. That charge "is not limited to the Medicare fee schedule" (ch. 30, sec. 50.9).
  • No proper ABN, no bill. If you should have gotten a notice and didn't, you're relieved of liability, and the provider has to refund anything it collected.
The three choices on a Medicare ABN
ABN optionWhat happensCan you appeal?
Option 1: Do the test and bill MedicareMedicare decides; the result comes on your Medicare Summary Notice. If Medicare denies, you pay. If it pays, the lab refunds what you paid, minus any cost sharingYes
Option 2: Do the test, don't bill MedicareYou pay the lab directly; no claim is filedNo
Option 3: Don't do the testNo test, no chargeNo

Source: CMS ABN form instructions (CMS-R-131); Claims Processing Manual ch. 30, sec. 50.17.

My read: if you think the test is needed and your doctor agrees, Option 1 is usually the one to pick, because it's the only path that keeps your appeal rights. Option 2 makes sense mainly when you already know Medicare won't pay and you want the test anyway. The lab can't pick an option for you; a pre-checked box makes the notice invalid.

If you have Apple Health or a Qualified Medicare Beneficiary program along with Medicare, the rules are different. CMS says dually eligible people must be told to check Option 1, and the provider can't bill you until both Medicare and Medicaid have decided the claim. More on that in Apple Health and Medicare.

The lab fee schedule and the proposed 2027 cuts

Medicare pays labs from the Clinical Laboratory Fee Schedule (CLFS). Since 2018, under the Protecting Access to Medicare Act of 2014 (PAMA), most rates have been based on the weighted median of what private payers pay for the same test. Labs report that private-payer data, and CMS normally resets rates every 3 years (CMS CLFS page).

In practice, Congress delayed the second round of reporting several times, and OIG notes rates have stayed the same since 2020. The Consolidated Appropriations Act, 2026 finally set it: data from the first half of 2025, reported May 1 to July 31, 2026.

On September 21, 2026, CMS published preliminary 2027 rates from that data. Its fact sheet says private-payer medians for 1,171 test codes came in lower than 2026 Medicare rates, 169 were equal and 186 were higher, with an average potential change of about 16% lower. CMS's press release estimated about $1 billion a year in savings. By law, no test's payment can drop more than 15% a year from 2027 through 2029, so the cuts phase in.

Preliminary 2027 lab rate changes by test category Potential weighted change vs 2026 Medicare CLFS rates, before the 15%-a-year cap
Proprietary lab analyses (151 codes)−2.4%Chemistry (387 codes)−16.0%Immunology (205 codes)−19.3%Microbiology (224 codes)−19.3%Molecular pathology (211 codes)−22.0%Genomic sequencing (42 codes)−23.0%

Source: CMS, Preliminary CY 2027 CLFS Payment Rates fact sheet (Sept. 21, 2026).

Show the numbers
Test categoryPotential change
Proprietary lab analyses (151 codes)−2.4%
Chemistry (387 codes)−16.0%
Immunology (205 codes)−19.3%
Microbiology (224 codes)−19.3%
Molecular pathology (211 codes)−22.0%
Genomic sequencing (42 codes)−23.0%

CMS said it expected to finalize 2027 rates in November 2026, effective January 1, 2027. As of November 16, the CLFS page hadn't posted final rates yet.

What this means for you: for a covered clinical lab test, very little. You pay nothing whatever Medicare pays the lab, so a lower rate doesn't change your bill. Where it can matter is indirect. Labs face lower payments, and the preliminary reductions are steepest for molecular pathology and genomic sequencing. Whether that changes which tests labs offer or how they handle ordering paperwork isn't something anyone can promise either way.

Medicare Part B spending on lab tests, 2018 to 2024 Tests paid under the Clinical Laboratory Fee Schedule, Original Medicare

Source: HHS OIG, Total Medicare Part B Spending on Lab Tests Rose in 2024 (OEI-09-25-00330).

Show the numbers
Spending
2018$7.7B
2019$7.7B
2020$8.1B
2021$9.4B
2022$8.4B
2023$8.0B
2024$8.4B

Spending peaked in 2021, during the COVID-19 public health emergency. The more telling trend is underneath: genetic tests were 5% of the lab tests Part B paid for in 2024 but 43% of the spending, $3.6 billion, up from 18% of spending in 2018. Meanwhile the number of people in Original Medicare who had any lab test fell 15% between 2018 and 2024, from 27.7 million to 23.4 million, which OIG says may reflect the shift into Medicare Advantage (OIG).

Genetic tests are also the expensive end of the menu. OIG says the single test with the highest Part B spending in 2024 was a genetic test with a median payment of $447 per claim. If you're handed an ABN for a genetic test, read the cost estimate line by line before you sign.

Home tests, Medicare Advantage, Medigap

Home COVID tests. During the public health emergency, Medicare paid for up to eight over-the-counter COVID-19 tests a month. That ended May 11, 2023. Since May 12, 2023, Part B doesn't cover or pay for over-the-counter COVID tests. A lab-run COVID test, like a PCR test your provider orders, is still covered with no deductible, coinsurance or copayment (CMS).

Medicare Advantage. A Medicare Advantage plan has to cover everything Part A and Part B cover and follow Medicare's national coverage determinations, including the lab NCDs (42 CFR 422.101). But plans can have their own network, referral and prior-authorization rules. Before you have blood drawn at a lab you haven't used, check that it's in network. The plan's Evidence of Coverage is the document that answers this, and CMS notes some plans cover over-the-counter COVID tests as an added benefit.

Medigap. A Medicare Supplement policy doesn't change anything for covered clinical lab tests, since there's no Original Medicare cost sharing to pick up. It can matter for the related bills that do carry coinsurance: surgical pathology, imaging, the hospital outpatient visit your labs were bundled into. More on Medicare Supplement insurance in Washington.

If you get a lab bill

Don't pay a lab bill on sight. Under Original Medicare, a bill for a covered clinical lab test should be rare, so one is worth checking.

  1. Find the claim on your Medicare Summary Notice or in your Medicare.gov account. Check whether Medicare paid, denied, or never got the claim. Here's how to read a Medicare Summary Notice.
  2. Look at what was billed. A pathology charge, a hospital outpatient charge, or an imaging charge isn't a clinical lab test, and those carry cost sharing.
  3. Ask whether you signed an ABN, and ask for a copy. If you didn't get a valid one and Medicare denied the test as not medically necessary, the lab generally can't bill you for it.
  4. If the denial was for diagnosis coding, call the ordering doctor's office. A missing or wrong diagnosis code is a common reason for a lab denial, and the office can tell you whether the order supports the test.
  5. Appeal by the date on the notice. The first level is a redetermination, filed by the deadline on your MSN; Medicare.gov says a decision generally comes within 60 days. The full process is in my post on the Medicare appeal process.

Help in Washington

Washington's Statewide Health Insurance Benefits Advisors (SHIBA), part of the Office of the Insurance Commissioner, gives unbiased Medicare help at no charge, including with bills, ABNs and appeals. Call the Insurance Consumer Hotline at 800-562-6900 (8:30 a.m. to 4:30 p.m., Monday through Friday, per the OIC) and ask for your local SHIBA office, or use the SHIBA contact form. During open enrollment, when I checked the OIC's local office directory on November 16, 2026, several listings said they weren't accepting appointments, so the hotline is the better first call. Here's how SHIBA works.

You can also call 1-800-MEDICARE (1-800-633-4227), TTY 1-877-486-2048. For the bigger picture of how Parts A and B fit together, see my overview of Medicare in Washington.

Your own coverage documents and Medicare's rules control how any claim is decided. Confirm your situation with a licensed agent, SHIBA, 1-800-MEDICARE or, for legal questions, an attorney.

Sources

  1. Medicare.gov: Diagnostic laboratory tests
  2. Medicare.gov: Diagnostic non-laboratory tests
  3. Medicare.gov: Cardiovascular disease screenings
  4. Medicare.gov: Diabetes screenings
  5. Medicare.gov: Hepatitis B virus (HBV) infection screenings
  6. Medicare.gov: Hepatitis C virus infection screenings
  7. Medicare.gov: HIV screenings
  8. Medicare.gov: Prostate cancer screenings
  9. Medicare.gov: Cervical & vaginal cancer screenings
  10. Medicare.gov: STI screenings & counseling
  11. Medicare.gov: Fecal occult blood tests
  12. Medicare.gov: Multi-target stool DNA tests
  13. Medicare.gov: Blood-based biomarker tests for colorectal cancer screening
  14. Medicare.gov: Appeals in Original Medicare
  15. Medicare.gov: Talk to someone
  16. CMS: Medicare Claims Processing Manual, Chapter 16, Laboratory Services
  17. CMS: Medicare Claims Processing Manual, Chapter 12, Physicians/Nonphysician Practitioners (sec. 60)
  18. CMS: Medicare Claims Processing Manual, Chapter 30, Financial Liability Protections
  19. CMS: National Coverage Determinations Manual, Chapter 1, Part 3 (190.12-190.34)
  20. CMS: ABN Form Instructions (CMS-R-131)
  21. eCFR: 42 CFR 410.32, Diagnostic tests: conditions
  22. eCFR: 42 CFR 422.101, Requirements relating to basic benefits
  23. CMS: Clinical Laboratory Fee Schedule (CLFS)
  24. CMS: Preliminary CY 2027 Medicare Clinical Laboratory Fee Schedule Payment Rates (fact sheet, Sept. 21, 2026)
  25. CMS: Preliminary Medicare payment rates for laboratory services (press release, Sept. 21, 2026)
  26. HHS OIG: Total Medicare Part B Spending on Lab Tests Rose in 2024 (OEI-09-25-00330)
  27. CMS: COVID-19 Over-the-Counter Tests
  28. CMS: 2026 Medicare Parts A & B Premiums and Deductibles
  29. Washington OIC: Statewide Health Insurance Benefits Advisors (SHIBA)
  30. Washington OIC: Office locations and hours
  31. Washington OIC: Find a local SHIBA office

Vadim Marusin

Vadim Marusin is a licensed independent insurance agent and the owner of Maru Insurance, serving Washington (WA License WAOIC #1365574) and Florida (FL License #G363233), NPN 22261820.

This article is for general educational purposes only and is not legal, tax or insurance advice. Coverage depends on the actual policy, its terms, conditions and exclusions, and state law. Maru Insurance · WA License (WAOIC) #1365574 · FL License #G363233 · NPN 22261820.